Invention Grant
- Patent Title: Heterocyclic compound
- Patent Title (中): 杂环化合物
-
Application No.: US14404126Application Date: 2013-05-31
-
Publication No.: US09371320B2Publication Date: 2016-06-21
- Inventor: Hiroshi Nara , Masaki Daini , Akira Kaieda , Toshihiro Imaeda , Fumiaki Kikuchi
- Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Applicant Address: JP Osaka
- Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee Address: JP Osaka
- Agency: Wenderoth, Lind & Ponack, LLP.
- Priority: JP2012-126462 20120601
- International Application: PCT/JP2013/065183 WO 20130531
- International Announcement: WO2013/180265 WO 20131205
- Main IPC: C07D401/14
- IPC: C07D401/14 ; A61K31/437 ; C07D471/04

Abstract:
The present invention provides a compound having a superior JAK inhibitory action, which is useful as an agent for the prophylaxis or treatment of autoimmune diseases (rheumatoid arthritis, psoriasis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus, etc.), cancer (leukemia, uterine leiomyosarcoma, prostate cancer, multiple myeloma, cachexia, myelofibrosis, etc.) and the like, or a salt thereof.The present invention relates to a compound represented by the formula wherein each symbol is as defined in the specification, or a salt thereof.
Public/Granted literature
- US20150141406A1 HETEROCYCLIC COMPOUND Public/Granted day:2015-05-21
Information query